![](https://investorshub.advfn.com/uicon/243166.png?cb=1526922418)
Tuesday, November 21, 2017 5:29:03 PM
Jonathan S. Maltz, Ph.D.
Chief Scientific Advisor
Dr. Maltz, received his PhD degree in Electrical Engineering from the University of California at Berkeley, and has over 16 years of experience designing new devices for assessing vascular function and evaluating these on human subjects. A paper describing one of his inventions for the evaluation of endothelial function won the best paper award from the journal Physiological Measurement in 2006. Another first-author paper describing a novel device he co-invented for performing imaging during radiation therapy won the best paper award from the journal Medical Physics in 2010. Dr Maltz is author of over 25 peer-reviewed publications, and holds 18 granted US patents. He was Principal Investigator on $3.8m NIH grant to develop methods for endothelial function assessment. This product leverages this large investment by the NIH. In addition to his academic contributions, Dr Maltz also has 11 years of experience in the field of commercial medical device R&D.
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM